Category Archives: Corporate

Latest From Corporate

BIO Welcomes Five New Board Members

Jim Greenwood

BIO elected five new members to its Board of Directors, voted upon at this year’s Board Meetings, held last week in Washington, DC. The following individuals were elected to the Health Section Governing Board: Francois Nader, President & CEO of NPS Pharmaceuticals, Inc. Anna Protopapas, President of Millennium: The Takeda Oncology Company Allen Waxman, Senior Vice President and General Counsel of Eisai, Inc. Klaus Wilgenbus, Senior Vice President, Business Development & Licensing of Boehringer Ingelheim Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags:

State Legislation Needed For Substitution of Interchangeable Biologics

Copyright sanofi pasteur

A great deal of the media coverage relating to California’s Senate Bill 598  neglects to mention a key issue in the biosimilars debate. This bill – or legislation similar to it – is essential to allow for the eventual substitution of interchangeable biologic therapies in the state of California. State laws governing prescription drug substitution were written before the advent of biosimilars and do not take the complexity of biologics into account. California, along with Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Jobs: The Talent Hub for Biotechnology

Jim Greenwood

The Biotechnology Industry Organization is proud to launch BIO Jobs, an online career resource where you can find the industry’s leading biotechnology employment opportunities all in one place. Visit jobs.bio.org to: Search for and quickly apply to a variety of positions available worldwide Set up job alerts so you are immediately notified any time a job is posted that matches your skills or interests Create an anonymous job seeker profile or upload your resume anonymously Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Nationwide Track and Trace System is Urgently Needed

Jim Greenwood

Today’s pharmaceutical distribution supply chain is governed largely by a patchwork of state laws and regulations that allows criminals to enter markets with the lowest safety requirements to inject counterfeit, unsafe, and potentially lethal products into the national supply chain. The state-by-state system is both onerous and ineffective, and the risk it poses to public health from counterfeiters can no longer be ignored. In a recent opinion piece for Roll Call, I write that: “Congress Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Twenty Years & Counting: Welcome to Chicago!

Jim Greenwood

Welcome to the 2013 BIO International Convention. It is hard to believe, but this year BIO reaches a significant milestone as we celebrate 20 years of bringing innovation, opportunity and growth to an industry that heals, fuels and feeds the world. From a small beginning – less than 1,500 people attended the first BIO meeting in 1993 – our Convention has grown into the most influential biotech gathering in the world, attracting thousands of industry Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,